TherapeuticsMD
TXMD
TXMD
140 hedge funds and large institutions have $711M invested in TherapeuticsMD in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 34
39% less capital invested
Capital invested by funds: $1.17B → $711M (-$459M)
Holders
140
Holding in Top 10
–
Calls
$1.92M
Puts
$1.67M
Top Buyers
| 1 | +$23M | |
| 2 | +$9.28M | |
| 3 | +$6.94M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$6.05M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.89M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$8.57M | |
| 3 | -$5.78M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$4.92M |
| 5 |
First Eagle Investment Management
New York
|
-$3.78M |